Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1636 1645
This examiner grants 100% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18594305 | WITHAFERIN A AND IMMUNE CHECKPOINT BLOCKER COMBINATION THERAPIES | Non-Final OA | University of South Florida |
| 18276052 | METHOD FOR INHIBITING CARDIAC FIBROBLAST TRANSDIFFERENTIATION | Non-Final OA | Zhejiang University |
| 18535116 | IMMUNOGENIC COMPOSITIONS AND METHODS FOR ELICITING AN IMMUNE RESPONSE AGAINST CLOSTRIDIOIDES (CLOSTRIDIUM) DIFFICILE | Non-Final OA | Pfizer Inc. |
| 18522521 | PERIPLASMIC LIGAND TRAPPING SYSTEM | Non-Final OA | UNIVERSITY OF MIAMI |
| 18542054 | THERMOSTABLE AFFINITY POLYPEPTIDES | Non-Final OA | Roche Diagnostics Operations, Inc. |
| 18581156 | APPLICATION OF ALKALI-TOLERANT MICROBIAL BACTERIA PDC-1 AND ITS IN-SITU REMEDIATION OF ORGANIC CONTAMINATED SOIL IN MINING AREAS | Non-Final OA | CHINESE RESEARCH ACADEMY OF ENVIRONMENTAL SCIENCES |
| 18580828 | PREVENTION AND/OR TREATMENT OF REWARD DYSREGULATION DISORDERS | Non-Final OA | UNIVERSITÉ CATHOLIQUE DE LOUVAIN |
| 18034120 | GENOME-MODIFIED BACTERIAL STRAINS FOR LARGE SCALE BIOPROCESSES | Non-Final OA | MANUS BIO INC. |
| 18546981 | NOVEL ANTI-PAD4 ANTIBODY | Non-Final OA | PHARMA FOODS INTERNATIONAL CO., LTD. |
| 18270485 | RECOMBINANT STRAIN WITH MODIFIED GENE BBD29_09525 FOR PRODUCING L-GLUTAMIC ACID, AND METHOD FOR CONSTRUCTING THE SAME AND USE THEREOF | Non-Final OA | INNER MONGOLIA EPPEN BIOTECH CO., LTD. |
| 18252048 | MYCOBACTERIAL IMMUNOTHERAPY FOR TREATING CANCER | Non-Final OA | IMMODULON THERAPEUTICS LIMITED |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy